These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1122003)

  • 1. Editorial: Bioavailability, bioequivalence and bias.
    Leopold IH
    Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003
    [No Abstract]   [Full Text] [Related]  

  • 2. Today's dilemma--will drugs work?
    Dowling HF
    J Am Pharm Assoc; 1971 Jun; 11(6):331-3. PubMed ID: 5118797
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.
    J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 5. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
    Hunnisett-Dritz D
    Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113
    [No Abstract]   [Full Text] [Related]  

  • 7. A history of biopharmaceutics in the Food and Drug Administration 1968-1993.
    Skelly JP
    AAPS J; 2010 Mar; 12(1):44-50. PubMed ID: 19936940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assuring total drug quality.
    Simmons HE
    J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
    [No Abstract]   [Full Text] [Related]  

  • 9. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Greed and Its Consequences.
    Jacobs HE
    Conn Med; 2016 May; 80(5):315-6. PubMed ID: 27328583
    [No Abstract]   [Full Text] [Related]  

  • 11. Statement of the APhA to the Subcommittee on Health United States Senate. 93rd Congress, 2nd session, Washington, D.C., July 22, 1974.
    Apple WS
    J Am Pharm Assoc; 1974 Oct; 14(10):572-6. PubMed ID: 4419654
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug development, regulation, and the practice of medicine.
    Wardell WM
    JAMA; 1974 Sep; 229(11):1457-61. PubMed ID: 4408186
    [No Abstract]   [Full Text] [Related]  

  • 13. World's drug supply chain needs better oversight, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2009 Jan; 66(1):12-3. PubMed ID: 19106338
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Bioequivalence and drug product selection.
    Zellmer WA
    Am J Hosp Pharm; 1974 Oct; 31(10):931. PubMed ID: 4440688
    [No Abstract]   [Full Text] [Related]  

  • 15. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP, other groups, advise FDA about solving counterfeit drug problems.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(23):2406, 2408, 2411. PubMed ID: 14686215
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Bioavailability data--useful or useless?
    Feldmann EG
    J Pharm Sci; 1975 Sep; 64(9):I. PubMed ID: 1185555
    [No Abstract]   [Full Text] [Related]  

  • 20. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.